EA3161

A Phase II/III Randomized Study of Maintenance Nivolumab versus Observation in Patients with Locally Advanced, Intermediate Risk HPV Positive OPCA
Contact phone
Clinical Trials Office – 517-364-9200
Principal investigator
Gordan Srkalovic, M.D., PhD
Trial Category
Cancer
Trial SubCategory
Head and Neck